Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of 5-aminolevulinic acid for fluorescence diagnosis in pancreatobiliary malignant tumors
jRCTs011210015Active, not recruiting
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in biliary cancer and pancreatic cancer (PC). Primary endpoint: Sensitivity of 5-ALA fluorescence for main tumor diagnosis. Started Sep 2021; status: active, not recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
biliary cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on jRCTs011210015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011210015.